Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |